Growth Metrics

Avanos Medical (AVNS) Cash & Current Investments (2016 - 2026)

Avanos Medical's Cash & Current Investments history spans 13 years, with the latest figure at $89.8 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 16.62% to $89.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.8 million, a 16.62% decrease, with the full-year FY2025 number at $89.8 million, down 16.62% from a year prior.
  • Cash & Current Investments hit $89.8 million in Q4 2025 for Avanos Medical, up from $70.5 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for AVNS hit a ceiling of $127.7 million in Q4 2022 and a floor of $70.5 million in Q3 2025.
  • Historically, Cash & Current Investments has averaged $97.8 million across 5 years, with a median of $97.4 million in 2021.
  • Biggest five-year swings in Cash & Current Investments: crashed 46.67% in 2021 and later grew 27.97% in 2025.
  • Tracing AVNS's Cash & Current Investments over 5 years: stood at $118.5 million in 2021, then grew by 7.76% to $127.7 million in 2022, then crashed by 31.32% to $87.7 million in 2023, then increased by 22.81% to $107.7 million in 2024, then dropped by 16.62% to $89.8 million in 2025.
  • Business Quant data shows Cash & Current Investments for AVNS at $89.8 million in Q4 2025, $70.5 million in Q3 2025, and $90.3 million in Q2 2025.